Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q1 2024 (March 31)8holders
$0.99avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings. The largest holders were Sonora Investment Management Group, LLC ($12.4M), Toronto Dominion Bank ($5.4M) and Jane Street Group, LLC ($1.1M).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $7.0M |
| Exits | 1 | $1K |
Ownership 8 holders
| Sonora Investment Management Group, LLC | 0.98% | Reduce -1.0% | 12,518,000 | $12.4M |
| Toronto Dominion Bank | 0.01% | New | 5,500,000 | $5.4M |
| Jane Street Group, LLC | 0.00% | New | 1,120,000 | $1.1M |
| Bank of New York Mellon Corp | 0.00% | No change | 800,000 | $792K |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | New | 500,000 | $495K |
| Sei Investments Co. | 0.00% | No change | 259,000 | $255K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -52.1% | 56,000 | $55K |
| Stephens Inc. | 0.00% | Add +48.5% | 49,000 | $48K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.